XML 14 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
Net sales $ 500.2 $ 549.0
Cost of products sold 416.2 461.3
Gross profit 84.0 87.7
Selling expense 18.5 20.4
Research and development expense 6.0 6.7
General expense 58.9 62.0
Total nonmanufacturing expenses 83.4 89.1
Restructuring and impairment expense 14.4 0.8
Operating loss (13.8) (2.2)
Interest expense 18.3 15.6
Other income (expense), net 1.7 (0.7)
Loss from continuing operations before income taxes (30.4) (18.5)
Income tax benefit, net (2.4) (3.0)
Net loss from continuing operations (28.0) (15.5)
Net income from discontinued operations 0.0 7.8
Net loss (28.0) (7.7)
Dividends to participating securities 0.0 (0.1)
Net loss attributable to Common Stockholders, basic (28.0) (7.8)
Net loss attributable to Common Stockholders, diluted $ (28.0) $ (7.8)
Net loss per share - basic:    
Loss per share from continuing operations (in dollars per share) $ (0.52) $ (0.28)
Income per share from discontinued operations (in dollars per share) 0 0.14
Basic (in dollars per share) (0.52) (0.14)
Net loss per share – diluted:    
Loss per share from continuing operations (in dollars per share) (0.52) (0.28)
Income per share from discontinued operations (in dollars per share) 0 0.14
Diluted (in dollars per share) $ (0.52) $ (0.14)
Weighted average shares outstanding:    
Basic (in shares) 54,267,900 54,483,000
Diluted (in shares) 54,267,900 54,483,000